Air Pollution and Polyclonal Elevation of Serum Free Light Chains: An Assessment of Adaptive Immune Responses in the Prospective Heinz Nixdorf Recall Study

被引:3
|
作者
Ohlwein, Simone [1 ]
Hennig, Frauke [1 ]
Lucht, Sarah [1 ]
Schmidt, Boerge [2 ]
Eisele, Lewin [2 ]
Arendt, Marina [2 ]
Duehrsen, Ulrich [3 ]
Duerig, Jan [3 ]
Joeckel, Karl-Heinz [2 ]
Moebus, Susanne [2 ,4 ]
Hoffmann, Barbara [1 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Med Fac, Inst Occupat Social & Environm Med, Dusseldorf, Germany
[2] Univ Duisburg Essen, Univ Hosp, Inst Med Informat Biometry & Epidemiol, Essen, Germany
[3] Univ Hosp Essen, Dept Hematol, Essen, Germany
[4] Univ Duisburg Essen, Univ Hosp Essen, Ctr Urban Epidemiol CUE, Inst Med Informat Biometry & Epidemiol IMIBE, Essen, Germany
关键词
SUBCLINICAL CORONARY ATHEROSCLEROSIS; PARTICULATE MATTER; NITROGEN-DIOXIDE; INFLAMMATORY RESPONSE; RESIDENTIAL EXPOSURE; PM2.5; EXPOSURE; AMBIENT PM2.5; MARKERS; PREDICT; ASSOCIATION;
D O I
10.1289/EHP7164
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
BACKGROUND: Residential exposure to air pollution (AP) has been shown to activate the immune system (IS). Although innate immune responses to AP have been studied extensively, investigations on the adaptive IS are scarce. OBJECTIVES: The aim of this study was to investigate the association between short- to long-term AP exposure and polyclonal free light chains (FLC) produced by plasma cells. METHODS: We used repeated data from three examinations (to: 2000-2003; t(1): 2006-2008; and t(2): 2011-2015) of the population-based German Heinz Nixdorf Recall cohort of initially 4,814 participants (45-75 y old). Residential exposure to total and source-specific particulate matter (PM) with an aerodynamic diameter of 10 or 2.5 mu m (PM10 and PM2.5 respectively), nitrogen dioxide (NO2), and particle number concentrations (accumulation mode; PNAM) was estimated using a chemistry transport model with different time windows (1- to 365-d mean +/- standard deviation) before blood draw. We applied linear mixed models with a random participant intercept to estimate associations between total, traffic- and industry-related AP exposures and log-transformed FLC, controlling for examination time, sociodemographic and lifestyle variables, estimated glomerular filtration rate and season. RESULTS: Analyzing 9,933 observations from 4,455 participants, we observed generally positive associations between AP exposures and FLC. We observed strongest associations with middle-term exposures, e.g., 3.0% increase in FLC (95% confidence interval: 1.8%, 4.3%) per interquartile range increase in 91-d mean of NO2 (14.1 mu g/m(3)). Across the different pollutants, NO2 showed strongest associations with FLC, followed by PM10 and PNAM. Effect estimates for traffic-related exposures were mostly higher compared with total exposures. Although NO2 and PNAM estimates remained stable upon adjustment for PM, PM estimates decreased considerably upon adjustment for NO2 and PNAM. DISCUSSION: Our results suggest that middle-term AP exposures in particular might be positively associated with activation of the adaptive IS. Traffic-related PM, PNAM, and NO2 showed strongest associations.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 29 条
  • [21] Cell Population Data and Serum Polyclonal Immunoglobulin Free Light Chains in the Assessment of COVID-19 Severity
    Malecka-Gieldowska, Milena
    Folta, Maria
    Wisniewska, Agnieszka
    Czyzewska, Emilia
    Ciepiela, Olga
    VIRUSES-BASEL, 2021, 13 (07):
  • [22] Cell population data and serum polyclonal immunoglobulin free light chains in the assessment of COVID-19 severity
    Gieldowska, Milena Malecka
    Gieldowska, Milena Malecka
    Ciepiela, Olga
    Ciepiela, Olga
    Wisniewska, Agnieszka
    Wisniewska, Agnieszka
    Czyzewska, Emilia
    Czyzewska, Emilia
    Folta, Maria
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 191 - 191
  • [23] Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?
    Hutchison, Colin A.
    Cockwell, Paul
    Harding, Steven
    Mead, Graham P.
    Bradwell, Arthur R.
    Barnett, Anthony H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2008, 12 (06) : 667 - 676
  • [24] SERUM FREE LIGHT CHAINS OF IMMUNOGLOBULINS ARE ASSOCIATED WITH DISEASE ACTIVITY IN SYSTEMIC SCLEROSIS: A PROSPECTIVE AND CONTROLLED STUDY
    Lanteri, A.
    Dubucquoi, S.
    Hachulla, E.
    Langlois, C.
    Lambert, M.
    Vuye, S.
    Hauspie, C.
    Hatron, P. -Y.
    Launay, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 560 - 560
  • [25] SERUM FREE LIGHT CHAINS OF IMMUNOGLOBULINS ARE ASSOCIATED WITH DISEASE ACTIVITY IN SYSTEMIC SCLEROSIS : A PROSPECTIVE AND CONTROLLED STUDY
    Lantieri, A.
    Dubucquoi, S.
    Hachulla, E.
    Langlois, C.
    Lambert, M.
    Vuye, S.
    Hauspie, C.
    Hatron, P.
    Launay, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S67 - S67
  • [26] Assessment of Serum Free Light Chains as a Marker of Diabetic Nephropathy; A Cross-Sectional Study in the Kumasi Metropolis
    Sorvor, Elizabeth
    Owiredu, William K. B. A.
    Okyere, Perditer
    Annani-Akollor, Max Efui
    Donkor, Sampson
    Bannor, Richard
    Sorvor, Felix B. K.
    Ephraim, Richard K. D.
    FRONTIERS IN CLINICAL DIABETES AND HEALTHCARE, 2022, 3
  • [27] Elevated serum free light chains and risk of non-Hodgkin lymphoma and the subtype follicular lymphoma in a prospective cohort study
    Hu, Wei
    Landgren, Ola
    Bassig, Bryan
    Purdue, Mark
    Engels, Eric
    Lan, Qing
    Rothman, Nathaniel
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Serum free light chains and the adaptive immune response in usual and alpha-1-antitrypsin deficiency-related chronic obstructive pulmonary disease
    Brebner, Judith
    Turner, Alice
    Ungurs, Michael
    Bharadwa, Pratibha
    Stockley, Robert
    LANCET, 2014, 383 : 28 - 28
  • [29] Pilot study: Profiling of individual responses to alemtuzumab immune reconstitution treatment by high frequency serum neurofilament light assessment in highly active RRMS patients up to 102 months can pre-identify clinical and MRI disease activity
    Akguen, K.
    Kretschmann, N.
    Proschmann, U.
    Haase, R.
    Kitzler, H.
    Reichmann, H.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1006 - 1007